文献速递临床试验与 GCP基础与转化研究

充分镇痛联合最小镇静作为自发性脑出血早期降压治疗的安全性和有效性:一项随机对照试验

Safety and efficacy of applying sufficient analgesia combined with a minimal sedation program as an early antihypertensive treatment for spontaneous intracerebral hemorrhage: a randomized controlled trial.
PubMed 文献 · Trials · 2018-11-06

本研究为多中心、前瞻性、随机对照、单盲、优效性临床试验,拟纳入354例中国自发性脑出血患者,比较瑞芬太尼联合右美托咪定与降压药(乌拉地尔、尼卡地平、拉贝洛尔)的降压方案。主要终点为治疗开始1小时内收缩压控制率,次要终点包括早期血肿扩大发生率、神经功能、ICU住院时长及工作人员满意度。研究假设充分镇痛联合最小镇静可作为有效且安全的脑出血降压策略。

要点

  • 比较瑞芬太尼联合右美托咪定与常规降压药对脑出血早期降压的效果。
  • 主要终点为治疗1小时内收缩压控制率,同时评估安全性和次要临床结局。
  • 研究假设充分镇痛联合最小镇静可作为脑出血急性期有效安全的降压策略。

核心结论

  • 研究假设充分镇痛联合最小镇静可作为自发性脑出血有效且安全的降压策略,并可能广泛用于急性期治疗。

研究设计与样本

  • 多中心、前瞻性、随机对照、单盲、优效性临床试验,在中国大陆15家医院开展。
  • 计划纳入354例受试者,随机分为实验组和对照组。

关键数值与推荐

  • 实验组给予瑞芬太尼联合右美托咪定,对照组给予降压药(乌拉地尔、尼卡地平、拉贝洛尔)。
  • 主要终点为治疗开始1小时内收缩压控制率。
  • 次要终点包括早期血肿扩大发生率、神经功能、ICU住院时长及工作人员对治疗过程的满意度。

临床怎么用

  • 若假设成立,充分镇痛联合最小镇静可作为脑出血急性期降压治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) is a serious threat to human health. Although early blood pressure (BP) elevation is closely associated with a poor prognosis, the optimal antihypertensive regimen for acute-phase ICH remains controversial. In ICH, pain, sleep deprivation, and stress are usually the main causes of dramatic BP increases. While traditional antihypertensive treatment resolves the increased BP, it does not address the root cause of the disease. Remifentanil relieves pain and, when combined with dexmedetomidine's antisympathetic action, can restore elevated BP to normal levels. Here, we seek to validate the efficacy and safety of applying sufficient analgesia in combination with a minimal sedation program versus antihypertensive drug therapy for the early and rapid stabilization of BP in ICH patients. METHODS/DESIGN: We are conducting a multicenter, prospective, randomized controlled, single-blinded, superiority clinical trial across 15 hospitals. We will enroll 354 subjects in mainland China, and all subjects will be randomized into experimental and control groups in which they will be given remifentanil combined with dexmedetomidine or antihypertensive drugs (urapidil, nicardipine, and labetalol). The primary endpoint will be the systolic BP control rate within 1 h of treatment initiation, and the efficacy and safety of the antihypertensive regimens will be compared between the two groups. Secondary endpoints include the incidence rate of early hemorrhage growth, neurological function, duration of intensive care unit (ICU) stay, and staff satisfaction with the treatment process. DISCUSSION: We hypothesize that applying sufficient analgesia in combination with minimal sedation will act as an effective and safe antihypertensive strategy in ICH and that this treatment strategy could, therefore, be widely used as an ICH acute-phase therapy. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03207100 . Registered on 22 July 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Dong R, Li F, Xu Y, et al. Safety and efficacy of applying sufficient analgesia combined with a minimal sedation program as an early antihypertensive treatment for spontaneous intracerebral hemorrhage: a randomized controlled trial. Trials. 2018. PMID: 30400977. doi:10.1186/s13063-018-2943-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。